News
Q2 2025 Earnings Call Transcript August 4, 2025 Syndax Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0 ...
During a live event, Hans Lee, MD, and participants discussed potential approaches to modifying frontline multiple myeloma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback